Clare Hague on drug pricing and market access

-Season 1: 12 Oct 2021

GOLD talks to Clare Hague, Senior Director, Haematology Market Access, Europe, the Middle East, and Africa, Janssen. She shares her perspective on the industry’s drug pricing challenges and opportunities, details alternative pricing systems that could improve access in low-to-middle-income countries, and explores the shifting market access landscape within oncology.

Additional resources

If you are interested in learning more about any of these subjects, check out the below articles from GOLD magazine:

• A conversation about drug pricing

• Leaving no patient behind

• Operation Vaccines: access all areas